177lu-psma-617
novartis
[' vision']
*suvmean&gt;10 . similar finding presented form vision trial today #asco2022 -&gt; should use psma suvmean to select patients for lutetium psma. note from vision - liver mets unsurprisingly associated with worse outcomes 
An Australian oncologist with an interest in GU malignancies, phase 1 trials, cycling and having fun with the family